DR. R. Blinder SRL
DR. R. Blinder reported total assets of €1.84m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jul 2026).
The score of DR. R. Blinder shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +20 % Total assets +23 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DR. R. Blinder's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 17 Aug 2023
- Year ended 31 Dec 2021filed on 19 Jul 2022
DR. R. Blinder's financial analysis
- Solvency82.1%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DR. R. Blinder
DR. R. Blinder's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0859.981.016
- VAT number
- BE0859981016
- Peppol
- Registered · 0208:0859981016 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Aug 2003
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 30 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
DR. R. Blinder (SRL) has been based in Uccle since 2003, active in: general medical practice activities. For 2025, it reports a net profit of 146,776 € and equity of €1.51m; its revenue is not published. Its solvency stands at 82.1%, above the median of its sector (69.3%).
Companies similar to DR. R. Blinder
Companies in the same business, of comparable size and area, outside its group.
- Generex, Docteur Andre Delforge Diagnostic imaging services and medical laboratory activities Vielsalm · balance sheet €1.53m
- DR. Peter Janssens General medical practice activities Oudenaarde · balance sheet 701,232 €
- DR. Carl Goeminne General medical practice activities Oudenaarde · balance sheet 567,038 €
- Dr. Marc Bloquiaux General medical practice activities Waregem · balance sheet 531,918 €
- LA MEDICALE DU BOCQ - Dr DEVILLE-MEDECINE GENERALE General medical practice activities Yvoir · balance sheet 525,594 €
- Dr. BART DOSSCHE General medical practice activities Oudenaarde · balance sheet €1.66m
- Cabinet Médical MOREAU PONCELET - Médecine générale General medical practice activities Bièvre · balance sheet €1.47m
- DR. Maris General medical practice activities Ninove · balance sheet €1.36m
Frequently asked questions about DR. R. Blinder
What is the revenue of DR. R. Blinder?
DR. R. Blinder files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DR. R. Blinder?
In Belgium, the VAT number is the company number prefixed with BE: BE0859981016 for DR. R. Blinder, if the company is VAT-registered. Its company number (CBE) is 0859.981.016.
Where is the registered office of DR. R. Blinder?
According to the CBE register, the registered office of DR. R. Blinder is in 1180 Uccle.
What is the equity of DR. R. Blinder?
At the close of the 2025 financial year, the equity of DR. R. Blinder amounts to 1,509,656 €, a solvency of 82.1% of total assets.
Who manages DR. R. Blinder?
The register lists 1 active mandates at DR. R. Blinder. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DR. R. Blinder
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →